Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This study is a multi-center, randomized, active-controlled, double-blind, non-inferiority, phase III clinical trial evaluating efficacy and safety of once-daily mosapride (UI05MSP015CT) in patients with functional dyspepsia.
Epistemonikos ID: 4fc706e70674fd2abf4cde2f69cb082ad1939808
First added on: May 21, 2024